ClinicalTrials.Veeva

Menu

Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome (splen ligation)

A

Aretaieion University Hospital

Status

Completed

Conditions

Splenic Artery
Small-For-Size Liver Syndrome
Ligation
Hepatectomy
Ischemia
Liver Regeneration
Reperfusion Injury
Portal Vein

Treatments

Procedure: splenic artery ligation

Study type

Observational

Funder types

Other

Identifiers

NCT05459883
418/18-04-2022

Details and patient eligibility

About

Our study aimed at assessing the changes of portal vein pressure, portal vein flow and hepatic arterial flow (HAF) in liver remnants ≤ 30% of the standard liver volume by reducing portal vein overflow via ligation of the splenic artery.

Full description

It has been reported that prevention of acute portal overpressure in small-for-size liver grafts leads to better postoperative outcomes. Accordingly, we aimed to investigate the feasibility of the technique of splenic artery ligation in a case series of patients subjected to major liver resections with evidence of small-for-size syndrome and whether the maneuver results in reduction of portal venous pressure and flow.

Enrollment

13 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients
  • American Society of Anesthesiologists (ASA) distribution I to III
  • Patients scheduled for major liver resection (≥4 segments)

Exclusion criteria

  • patients with extrahepatic disease
  • patients with metastatic liver tumors

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems